CTX — Captor Therapeutics SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN147.20m
- PLN113.58m
- PLN15.83m
Annual cashflow statement for Captor Therapeutics SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.7 | -32.6 | -35.9 | -70.6 | -38.4 |
| Depreciation | |||||
| Non-Cash Items | 1.75 | 9.53 | 7.89 | 4.46 | 1.86 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.75 | -12.8 | -2.04 | 8.48 | -0.37 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.595 | -28.5 | -22.9 | -52.2 | -31.9 |
| Capital Expenditures | -0.212 | -5.11 | -0.892 | -3 | -0.424 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -16.7 | 22.9 | 0.697 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.212 | -5.11 | -17.6 | 19.9 | 0.273 |
| Financing Cash Flow Items | — | -0.409 | -0.575 | -0.318 | -0.385 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.881 | 141 | -6.33 | 36.9 | -4.84 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.69 | 107 | -46.9 | 4.67 | -36.4 |